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Sir:
Surgical site infections (SSIs) have been reported as the most common causes of readmission after 
plastic surgery.1 In July 2013, the U.S. Centers for 
Disease Control and Prevention and Missouri State 
Health Department investigated reports of 5 SSI 
cases following breast augmentation surgeries. The 
case-patients’ surgeries were performed at a single 
outpatient plastic surgery clinic (clinic A) during 
May–June 2013. An epidemiologic investigation was 
performed with the cooperation and support of 
the clinic and the surgeon who detected the cluster 
among his patients.
We defined a case as a patient who had surgery 
at clinic A between May and July 2013, with subse-
quent signs or symptoms of SSI, which include any 
of the following: pain, redness, swelling, discharge 
at the wound, or unhealed wound. We identified 
8 case-patient: 6 following breast augmentation us-
ing a solid implant and 2 following face lift surgery. 
The first case-patient had breast surgery in May 2013 
and developed symptoms after 4–6 weeks. This case 
had Mycobacterium identified by polymerase chain 
reaction from a breast tissue sample; the remaining 
case-patients had negative microbiological testing. 
All case-patients experienced mild pain and tender-
ness, some discharge and delayed wound healing. 
All of the case-patients’ procedures were performed 
by the same surgeon. Cases seemed to occur after 
the surgeon switched, in April 2013, to a different 
lubricating gel product to assist with implant inser-
tions. Review of clinic records showed that the clin-
ic’s overall SSI rate was 0.2% (13 cases) during 12 
months prior to this cluster.
We reviewed the steps of a breast augmentation 
surgery with the surgeon and observed infection 
control practices at clinic A. Instead of using dis-
posable implants or Food and Drug Administration 
(FDA)-approved resterilizable implants as sizers, ac-
tual single-use implants were reused by subjecting 
them to enzymatic cleansing and steam sterilization. 
Testing of one implant that had been reprocessed 
in this manner identified alpha Streptococcus and 
coagulase-negative Staphylococcus species. The afore-
mentioned lubricating gel was used around the inci-
sion sites and on the sizers and implants. The gel 
was labeled bacteriostatic and as being intended to 
lubricate body orifices and facilitate entry of diag-
nostic and therapeutic devices. However, testing of 
only one available open unused tube of gel at U.S. 
Centers for Disease Control and Prevention did not 
identify mycobacteria or other pathogens.
In response to the cluster, the surgeon temporar-
ily discontinued breast augmentation surgery. When 
surgery was restarted, FDA-approved resterilizable 
implants were used as sizers, and the surgeon revert-
ed to the previous brand of lubricating gel, which 
had similar labeling as the gel mentioned above. No 
new cases have been reported to date.
Although a definitive mode of transmission was 
not determined, our investigation identified possi-
ble sources of infections and raised some important 
points for plastic surgeons to consider. Growth of 
bacteria from the tested sizer indicated one poten-
tial source of infection; reuse of single-use implants 
as sizers may be unsafe as this is neither approved 
by FDA nor recommended by the manufacturer. In 
addition, the use of lubricating gel directly on sterile 
tissues during operations represented another po-
tential source of infection. These gel products are 
not indicated for that purpose; we are not aware of 
any lubricating gel products that are labeled for use 
on sterile surgical fields. The labeling of these gels 
may require clarification and greater specificity in 
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this regard. In summary, we recommend that sur-
geons adhere carefully to manufacturer instructions, 
use only FDA-approved reusable or single-use sizers, 
and not use lubricating gel products on sterile tis-
sues for placement of these devices. 
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